Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXHB2200081	SAL0104胶囊	SAL-0104	Capsule	Chemical Drugs(1)	Supplementary Application	2022-06-14		Shenzhen Salubris Pharmaceuticals Co Ltd			view
CXHB2200082	SAL0104胶囊	SAL-0104	Capsule	Chemical Drugs(1)	Supplementary Application	2022-06-14		Shenzhen Salubris Pharmaceuticals Co Ltd			view
CXHB2101029	SAL0104胶囊	SAL-0104	Capsule	Chemical Drugs(1)	Supplementary Application	2021-05-17		Shenzhen Salubris Pharmaceuticals Co Ltd			view
CXHB2101028	SAL0104胶囊	SAL-0104	Capsule	Chemical Drugs(1)	Supplementary Application	2021-05-17		Shenzhen Salubris Pharmaceuticals Co Ltd			view
CXHB2101027	SAL0104胶囊	SAL-0104	Capsule	Chemical Drugs(1)	Supplementary Application	2021-05-13		Shenzhen Salubris Pharmaceuticals Co Ltd			view
CXHB2101026	SAL0104胶囊	SAL-0104	Capsule	Chemical Drugs(1)	Supplementary Application	2021-05-13		Shenzhen Salubris Pharmaceuticals Co Ltd			view
CXHL2100022	SAL0104胶囊	SAL-0104	Capsule	Chemical Drugs(1)	New Drug Application	2021-01-16	深圳信立泰药业股份有限公司	Shenzhen Salubris Pharmaceuticals Co Ltd	In Review	2021-01-15	view
CXHL2100023	SAL0104胶囊	SAL-0104	Capsule	Chemical Drugs(1)	New Drug Application	2021-01-14	深圳信立泰药业股份有限公司	Shenzhen Salubris Pharmaceuticals Co Ltd	In Review	2021-01-13	view
CXHL2100020	SAL0104胶囊	SAL-0104	Capsule	Chemical Drugs(1)	New Drug Application	2021-01-13	深圳信立泰药业股份有限公司	Shenzhen Salubris Pharmaceuticals Co Ltd	In Review	2021-01-12	view
CXHL2100021	SAL0104胶囊	SAL-0104	Capsule	Chemical Drugs(1)	New Drug Application	2021-01-13	深圳信立泰药业股份有限公司	Shenzhen Salubris Pharmaceuticals Co Ltd	In Review	2021-01-12	view